Dr. Robert Krzesz

Senior Manager Clinical Operations, Franchise Lead, CNS

Lörrach, Baden-Württemberg, Germany

About

Robert is a clinical researcher currently working as Senior COM, Franchise Lead at Worldwide Clinical Trials. During his 15+ years long career in pharmaceutical and CRO industry he conducted numerous phase I-IV adult and pediatric clinical trials in the fields of cardiology, CNS, oncology, endocrinology, metabolic and autoimmune diseases. In everyday work he employs his broad experience and in-depth knowledge of all operational stages of clinical trial as well as the understanding of scientific concept and protocol writing. Robert is also an author of several scientific publications on understanding the pathomechanism of autoimmune and cardiovascular diseases and during his 12 years long academic career he did a lot of teaching and was involved in molecular diagnostic of viral infections and chromosomal translocation.

Experience

  • Senior Manager Clinical Operations - Franchise Lead, CNS at Worldwide Clinical Trials
    Nov 2023 - Present · 2 yrs 8 mos

  • Director Clinical Operations at BioNTech SE
    Mar 2023 - Sep 2023 · 7 mos

  • Worldwide Clinical Trials (9 yrs 2 mos)
    • Senior Manager Clinical Operations - Franchise Lead
      Sep 2022 - Feb 2023 · 6 mos

    • Clinical Operations Manager - Franchise Lead
      Oct 2018 - Sep 2022 · 4 yrs

    • Lead CRA
      Feb 2017 - Sep 2018 · 1 yr 8 mos

      Lead CRA on 4 trials, having also Project Manager tasks like finance reporting, sponsor invoicing, budget overview, change order preparation.

  • Clinical Scientist at Grünenthal
    Oct 2011 - Oct 2012 · 1 yr 1 mo

    Study Team Lead responsible for development and writing of 3 synopsis, 2 protocols and other regulatory documents and Clinical Expert supporting setup of clinical trial. Indication: Moderate to Severe (Cancer) Pain Additional contribution: Member of Grünenthal “Clinical Trial Policy” working group.

  • CRA at ICON plc
    Jul 2006 - Sep 2011 · 5 yrs 3 mos

    Monitoring activities in 6 clinical trials Therapeutic areas of monitoring activities include: Oncology: Head and neck cancer; Lung cancer Hormonal dysfunction: Growth-Hormone Deficiency Autoimmune diseases: Morbus Crohn